Degarelix
CAS: 214766-78-6
Ref. 3D-PIA76678
| 1mg | Descatalogado | ||
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado |
Información del producto
Nombre:
Degarelix
Sinónimos:
- Firmagon
- D-Alaninamide,N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-leucyl-N6-(1-methylethyl)-L-ly
Descripción:
Degarelix is a gonadotropin-releasing hormone (GnRH) antagonist that inhibits the production of testosterone by the testes. It can be used to treat prostate cancer and other conditions caused by high levels of testosterone. Degarelix is an injectable, long-acting GnRH antagonist that is administered in three doses over a period of four months. The drug blocks the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which are hormones that regulate the production of testosterone by the testes. Degarelix has been shown to improve survival rates for patients with advanced prostate cancer without causing weight gain or sexual dysfunction.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
1,632.26 g/mol
Fórmula:
C82H103ClN18O16
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
